Incidence of Myocardial Infarction and Vascular Death in Elderly Patients With Atrial Fibrillation Taking Anticoagulants
Daniele Pastori(Sapienza University of Rome), Francesco Violi(Sapienza University of Rome), Tommaso Bucci(University of Liverpool), Gregory Y.H. Lip(University of Liverpool), Valeria Raparelli(Sapienza University of Rome), Roberto Cangemi(Sapienza University of Rome), Gaetano Tanzilli(Sapienza University of Rome), Alessio Farcomeni(Department of Public Health), Francesco Angelico(Policlinico Umberto I), Pasquale Pignatelli(Sapienza University of Rome), Tommasa Vicario(Sapienza University of Rome), Maria Del Ben(Sapienza University of Rome)
Cited by 68
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919